In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Evidence, guidelines, clinical practice – The evolving role of cardiologists in the SGLT2 inhibitor era
Session

Event : ESC Congress 2019

Topic : Risk Factors and Prevention

  • Session type : Satellite Symposium - Experts on the Spot
  • Date : 01 September 2019
  • Time : 18:00 - 18:30
  • Sponsored by The Boehringer Ingelheim and Eli Lilly and Company Alliance

2 presentations in this session

Welcome and introduction

Event : ESC Congress 2019

  • Session : Evidence, guidelines, clinical practice – The evolving role of cardiologists in the SGLT2 inhibitor era
  • Speaker : N Marx (Aachen,DE), S Anker (Berlin,DE)
  • Sponsored by The Boehringer Ingelheim and Eli Lilly and Company Alliance

Evidence, guidelines, clinical practice – The evolving role of cardiologists in the SGLT2 inhibitor era

Event : ESC Congress 2019

  • Session : Evidence, guidelines, clinical practice – The evolving role of cardiologists in the SGLT2 inhibitor era
  • Speaker : N Marx (Aachen,DE), S Anker (Berlin,DE)
  • Sponsored by The Boehringer Ingelheim and Eli Lilly and Company Alliance

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are